Zimmer Biomet Holdings, Inc. Announces Preliminary Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2016; Revises Earnings Guidance for the Year 2016
For the year, the company's net sales were $7,684 million.
For the year 2016, the company expects full-year 2016 diluted earnings per share, without unreasonable efforts, as the company is finalizing the accounting for certain integration-related items that are excluded from the computation of adjusted diluted earnings per share. The company now expects full year 2016 adjusted diluted earnings per share to be towards the upper end of the previously estimated range of $7.90 to $7.95.